See the original post:
ProQR Announces Virtual Presentation of Phase 1/2 Sepofarsen Extension Trial Data at the Association for Research in Vision and Ophthalmology (ARVO)...

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh